Principal Scientist (Director), Clinical Research, Atherosclerosis
Merck & Co., Inc. - USA - New Jersey - Rahway
Posted Nov 3, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- $256K-$403K From the posting source checked Nov 16, 2026
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $81,444 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +6.9% - Faster than average
304% above the BLS role benchmark for healthcare aggregate.
Posted salary is far from this role benchmark; treat it as low confidence.
Matched to SOC 29-1141 - Healthcare aggregate by role bucket.
Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.
Role
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 16, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Principal Scientist (Director), Clinical Research, Atherosclerosis USA - New Jersey - Rahway Job Description The Director (Principal Scientist) has primary responsibility for the planning and directing clinical research activities involving new or marketed medicines in the Atherosclerosis section of the Atherosclerosis & Metabolism therapeutic area. Our company's Atherosclerosis & Metabolism medicines span all phases of clinical development (pre-clinical to post-licensure). The Director will manage the entire cycle of clinical development for late-stage studies, including study design, initiation, execution, monitoring, analysis, regulatory reporting, and publication. Specifically, The Director May Be Responsible For: Planning clinical trials (design, operational plans, settings) based on these clinical development strategies Monitoring and managing the conduct of ongoing or new clinical trials for investigational or marketed Atherosclerosis & Metabolism drugs; Analyzing and summarizing the clinical findings from studies to support decisions regarding safety and efficacy as well as new drug applications, clinical study reports, or publication; and Participation in internal and joint internal/external research project teams relevant to the development of new compounds, and the further study of marketed compounds. Support of business development assessments of external opportunities The Director may: Collaborate with the Clinical Scientists in the execution of clinical studies. Work closely with a cross-functional group of experts in commercialization, regulatory affairs, statistics, and manufacturing to manage clinical development projects; and assist the team in ensuring that appropriate Corporate personnel are informed of the progress of studies of our company and competitors' drugs, and of internal and external expert opinion on scientific questions relevant to
Read the full description at msd.wd5.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Associate Principal Scientist, Clinical Research
Merck & Co., Inc. - USA - New Jersey - Rahway
Director, Clinical Sciences
Keros Therapeutics Inc - Lexington, MA (Hybrid)
Director, Clinical Sciences
Amylyx Pharmaceuticals Inc - Cambridge, MA
Director, Clinical Development
Acadia Pharmaceuticals Inc - Princeton, New Jersey, United States; San Diego, California, United States; South San Francisco, California, United States